BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 15723449)

  • 41. High risk occupations for non-Hodgkin's lymphoma in New Zealand: case-control study.
    't Mannetje A; Dryson E; Walls C; McLean D; McKenzie F; Maule M; Cheng S; Cunningham C; Kromhout H; Boffetta P; Blair A; Pearce N
    Occup Environ Med; 2008 May; 65(5):354-63. PubMed ID: 18032530
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
    Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
    Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk of primary non-hepatocellular malignancies in hereditary hemochromatosis.
    Geier D; Hebert B; Potti A
    Anticancer Res; 2002; 22(6B):3797-9. PubMed ID: 12552996
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Incidence of non-Hodgkin's lymphoma in Sweden, Denmark, and Finland from 1960 through 2003: an epidemic that was.
    Sandin S; Hjalgrim H; Glimelius B; Rostgaard K; Pukkala E; Askling J
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1295-300. PubMed ID: 16835326
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
    Salzburg J; Burkhardt B; Zimmermann M; Wachowski O; Woessmann W; Oschlies I; Klapper W; Wacker HH; Ludwig WD; Niggli F; Mann G; Gadner H; Riehm H; Schrappe M; Reiter A
    J Clin Oncol; 2007 Sep; 25(25):3915-22. PubMed ID: 17761975
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence of HCV among Yemeni patients with non-Hodgkin's lymphoma at AI-Thawra teaching hospital.
    Salem AK
    Gulf J Oncolog; 2009 Jan; (5):22-9. PubMed ID: 20084782
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk of subsequent solid tumors after non-Hodgkin's lymphoma: effect of diagnostic age and time since diagnosis.
    Hemminki K; Lenner P; Sundquist J; Bermejo JL
    J Clin Oncol; 2008 Apr; 26(11):1850-7. PubMed ID: 18347006
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changing epidemiology and risk factors for gastrointestinal non-Hodgkin's lymphoma in a North American population: population-based study.
    Andrews CN; John Gill M; Urbanski SJ; Stewart D; Perini R; Beck P
    Am J Gastroenterol; 2008 Jul; 103(7):1762-9. PubMed ID: 18557717
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Monitoring serum hepatitis C virus (HCV) RNA in patients with HCV-infected CD20-positive B-cell lymphoma undergoing rituximab combination chemotherapy.
    Ennishi D; Terui Y; Yokoyama M; Mishima Y; Takahashi S; Takeuchi K; Okamoto H; Tanimoto M; Hatake K
    Am J Hematol; 2008 Jan; 83(1):59-62. PubMed ID: 17712791
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Second cancers in hematologic malignancies (epidemiologic observations from a 20-year period)].
    Jakó J; Szerafin L; Nagy P
    Orv Hetil; 2005 Mar; 146(10):461-9. PubMed ID: 15835344
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association between immune thrombocytopenic purpura and chronic lymphocytic leukemia in a patient carrier of anti-hepatitis C virus antibodies.
    Numeroso F; Baroni MC; Delsignore R
    Ann Ital Med Int; 2005; 20(3):197-202. PubMed ID: 16250187
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis.
    d'Arminio Monforte A; Cozzi-Lepri A; Castagna A; Antinori A; De Luca A; Mussini C; Caputo SL; Arlotti M; Magnani G; Pellizzer G; Maggiolo F; Puoti M;
    Clin Infect Dis; 2009 Aug; 49(4):612-22. PubMed ID: 19591597
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
    Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Renal parenchymal tumors and lymphoma in the same patient: case series and review of the literature.
    Kunthur A; Wiernik PH; Dutcher JP
    Am J Hematol; 2006 Apr; 81(4):271-80. PubMed ID: 16550521
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Aquitaine Cohort, France.
    Bonnet F; Balestre E; Thiébaut R; Morlat P; Pellegrin JL; Neau D; Dabis F;
    Clin Infect Dis; 2006 Feb; 42(3):411-7. PubMed ID: 16392091
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Second malignancies after treatment of diffuse large B-cell non-Hodgkin's lymphoma: a GISL cohort study.
    Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Gobbi PG; Angrilli F; Brugiatelli M; Musto P; Federico M
    Haematologica; 2008 Sep; 93(9):1335-42. PubMed ID: 18698083
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A phase I/II study examining pentostatin, chlorambucil, and theophylline in patients with relapsed chronic lymphocytic leukemia and non-Hodgkin's lymphoma.
    Willis CR; Goodrich A; Park K; Waselenko JK; Lucas M; Reese A; Diehl LF; Grever MR; Byrd JC; Flinn IW
    Ann Hematol; 2006 May; 85(5):301-7. PubMed ID: 16518606
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma.
    Brown JR; Yeckes H; Friedberg JW; Neuberg D; Kim H; Nadler LM; Freedman AS
    J Clin Oncol; 2005 Apr; 23(10):2208-14. PubMed ID: 15753460
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Profiles and prognostic values of serum LDH isoenzymes in patients with haematopoietic malignancies.
    Bouafia F; Drai J; Bienvenu J; Thieblemont C; Espinouse D; Salles G; Coiffier B
    Bull Cancer; 2004; 91(7-8):E229-40. PubMed ID: 15381461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.